1.14
1.72%
-0.02
Oncternal Therapeutics Inc (ONCT) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
91.58%
0.569
|
0.297 | 0.179 | 0.106 | 0.203 |
Operating Expenses |
5.89%
9.348
|
9.933 | 10.57 | 9.651 | 12.35 |
Benefits Costs and Expenses |
5.33%
8.957
|
9.461 | - | - | 11.69 |
Costs And Expenses |
5.33%
8.957
|
9.461 | 10.57 | 9.651 | 11.69 |
Operating Income/Loss |
8.89%
-8.779
|
-9.636 | -10.39 | -9.545 | -12.14 |
Income/Loss From Continuing Operations Before Tax |
8.47%
-8.388
|
-9.164 | 0.179 | 0.106 | -11.49 |
Income/Loss From Continuing Operations After Tax |
8.47%
-8.388
|
-9.164 | -9.862 | -8.966 | -11.49 |
Net Income/Loss
|
8.47%
-8.388
|
-9.164 | -9.862 | -8.966 | -11.49 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
105.30%
2.959
|
-55.80 | 58.96 | 58.72 | 58.52 |
Diluted Average Shares |
105.30%
2.959
|
-55.80 | 58.96 | 58.72 | 58.52 |
Basic Earnings Per Share |
78.08%
-2.83
|
-12.91 | -0.17 | -0.15 | -0.20 |
Diluted Earnings Per Share |
78.08%
-2.83
|
-12.91 | -0.17 | -0.15 | -0.20 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):